Soluble tumor necrosis factor (TNF) receptors (sTNF-R1 and -R2) in pregnant women chronically infected with Trypanosoma cruzi and their children

American Journal of Tropical Medicine and Hygiene

Volumn 78, Issue 3, 2008, Pages 499-503

  García, Miriam Martin ^a,c   De Rissio, Ana Maria ^a,c   Villalonga, Ximena ^a,c   Mengoni, Eleonora ^a,c   Cardoni, Rita L ^a,b,c  

^a Administracion Nacional de Laboratorios E Institutos de Salud Dr Carlos G Malbran   (Argentina)

^b Instituto Nacional de Parasitología Dr M Fatala Chabén ^*  (Argentina)

^c Instituto Nacional de Diagnostico e Investigacion de la Enfermedad de Chagas Dr Mario Fatala Chaben   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; NEWBORN; PREGNANCY; PREGNANT WOMAN; PREMATURITY; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS; VERTICAL TRANSMISSION; ADOLESCENT; AGING; ANIMAL; BLOOD; CHAGAS DISEASE; CHRONIC DISEASE; GENETICS; INFANT; LEUKOCYTE; METABOLISM; PREGNANCY COMPLICATION; SOLUBILITY;

TRYPANOSOMA CRUZI;

ADOLESCENT; ADULT; AGING; ANIMALS; CHAGAS DISEASE; CHRONIC DISEASE; DISEASE TRANSMISSION, VERTICAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTERLEUKIN-10; LEUKOCYTES; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SOLUBILITY; TRYPANOSOMA CRUZI; TUMOR NECROSIS FACTOR-ALPHA;

EID: 42949170917     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2008.78.499     Document Type: Article

References (32)

1. Schmuñis GA, 1999. A Tripanossomiase Americana e seu impacto na saúde pública das Americas. Brener Z, Andrade ZA, Barrai Neto M, eds. Trypanosoma cruzi e Doenca de Chagas. Rio de Janeiro: Guanabara Koogan, 1-15.
2. Gürtler RE, Segura EL, Cohen JE, 2003. Congenital transmission of Trypanosoma cruzi infection in Argentina. Emerg Infect Dis 9: 29-32.
3. Arcavi M, Orfus G, Griemberg G, 1993. Incidencia de la infección chagásica en embarazadas y recién nacidos en área no endémica. Medicina (B Aires) 53: 217-222.
4. Storni P, Bolsi FL, 1979. Embarazo y parasitismo por Trypanosoma cruzi. Medicina (B Aires) 39: 193-197.
5. Szarfman A, Urman J, Otalova A, Larzuia A, Yanovsky JF, 1975. Specific agglutinins and immunoglobulin levels in congenital Chagas disease. Medicina (B Aires) 35: 245-250.
6. Votta RA, Marchese CA, Pastorini A, Gonzalez CA, Lautrec L, Tomassini TL, 1977. Multimetodología diagnóstica de la enfermedad de Chagas Mazza congénita en un medio no endémico. Revista de la Sociedad de Obstetricia y Ginecología de Buenos Aires 56: 237-250.
7. Freilij H, Altcheh J, 1995. Congenital Chagas disease: diagnosis and clinical aspects. Clin Infect Dis 21: 551-555.
8. Hermann E, Truyens C, Alonso Vega C, Rodriguez P, Berthe A, Torrico F, Carlier Y, 2004. Congenital transmission of Trypanosoma cruzi is associated with maternal enhanced parasitemia and decreased production of Interferon-γ in response to parasite antigens. J Infect Dis 189: 1274-1281.
9. Santos Lima EC, Garcia I, Vicentelli MH, Vassalli P, Minoprio P, 1997. Evidence for a protective role of tumor necrosis factor in the acute phase of Trypanosoma cruzi infection in mice. Infect Immun 65: 457-465.
10. Hölscher C, Köhler G, Müller U, Mossmann H, Schaub GA, Brombacher F, 1998. Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect Immun 66: 1208-1215.
11. Köberle F, 1968. Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis. Adv Parasitol 6: 63-116.
12. Perez-Fuentes R, Guegan JF, Barnabe C, Lopez-Colombo A, Salgado-Rosas H, Torres-Rasgado E, Briones B, Romero-Díaz M, Ramos-Jimenez J, Sánchez-Guillen M del C, 2003. Severity of chronic Chagas disease is associated with cytokine/antioxidant imbalance in chronically infected individuals. Int J Parasitol 33: 293-299.
13. Derouich-Guergour D, Brenier-Pinchart MP, Ambroise-Thomas P, Pelloux H, 2001. Tumour necrosis factor α receptors: role in the physiopathology of protozoan parasite infections. Int J Parasitol 31: 763-769.
14. Cardoni RL, García MM, De Rissio AM, 2004. Proinflammatory and anti-inflammatory cytokines in pregnant women chronically infected with Trypanosoma cruzi. Acta Trop 90: 65-72.
15. Cura EN, Segura EL, 1998. Quality assurance of the serologic diagnosis of Chagas disease. Rev Panam Salud Publica/Pan Am/Public Health 3: 242-248.
16. Guía para la atención al paciente infectado con Trypanosoma cruzi. Ministerio de Salud, 2006. Resolution 1870. Available at: www.msal.gov.ar/htm/site/chagas. Accessed August 10, 2007.
17. Svahn A, Linde A, Thorstensson R, Karlen K, Andersson L, Gaines H, 2003. Development and evaluation of a flow-cytometric assay of specific cell-mediated immune response in activated whole blood for the detection of cell-mediated immunity against varicella-zoster virus. J Immunol Methods 277: 17-25.
18. Leeuwenberg JF, Jeunhomme TM, Buurman WA, 1994. Slow release of soluble TNF receptors by monocytes in vitro. J Immunol 152: 4036-4043.
19. Joyce DA, Gibbons DP, Green P, Steer JH, Feldmann M, Brennan FM, 1994. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes. Eur J Immunol 24: 2699-2705.
20. Raghupathy R, 1997. Th1-type immunity is incompatible with successful pregnancy. Immunol Today 18: 478-482.
21. Steinborn A, Gunes H, Halberstadt E, 1995. Signal for term parturition is of trophoblast and therefore of fetal origin. Prostaglandins 50: 237-252.
22. Steinborn A, Gunes H, Roddiger S, Halberstadt E, 1996. Elevated placental cytokine release, a process associated with preterm labor in the absence of intrauterine infection. Obstet Gynecol 88: 534-539.
23. Joyce DA, Steer JH, Abraham LJ, 1997. Glucocorticoid modulation of human monocyte/macrophage function: control of TNF-α secretion. Inflamm Res 46: 447-451.
24. Snyder SK, Wessner DH, Wessells JL, Waterhouse RM, Wahl LM, Zimmermann W, Dveksler GS, 2001. Pregnancy-specific glycoproteins function as immunomodulators by inducing secretion of IL-10, IL-6 and TGF-β1 by human monocytes. Am J Reprod Immunol 45: 205-216.
25. Chernyshov VP, Vodyanik MA, Pisareva SP, 2005. Lack of soluble TNF-receptors in women with recurrent spontaneous abortion and possibility for its correction. Am J Reprod Immunol 54: 284-291.
26. Vekemans J, Truyens C, Torrico F, Solano M, Torrico MC, Rodriguez P, Alonso-Vega C, Carlier Y, 2000. Maternal Trypanosoma cruzi infection upregulates capacity of uninfected neonate cells to produce pro- and anti-inflammatory cytokines. Infect Immun 68: 5430-5434.
27. Kwiatkowski D, Hill AV, Sambou I, Twumasi P, Castracane J, Manogue KR, Cerami A, Brewster DR, Greenwood BM, 1990. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336: 1201-1204.
28. Zwingenberger K, Harms G, Pedrosa C, Pessoa MC, Sandkamp B, Scheibenbogen C, Andreesen R, 1991. Generation of cytokines in human visceral leishmaniasis: dissociation of endogenous TNF-α and IL-1β production. Immunobiology 183: 125-132.
29. Shobokshi A, Shaarawy M, 2002. Maternal serum and amniotic fluid cytokines in patients with preterm premature rupture of membranes with and without intrauterine infection. Int J Gynaecol Obstet 79: 209-215.
30. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF, 1992. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor α in vitro and in vivo. Proc Natl Acad Sci USA 89: 4845-4849.
31. Austgulen R, Liabakk NB, Brockhaus M, Espevik T, 1992. Soluble TNF receptors in amniotic fluid and in urine from pregnant women. J Reprod Immunol 22: 105-116.
32. Doellner H, Arntzen KJ, Haereid PE, Aag S, Brubakk AM, Austgulen R, 1998. Increased serum concentrations of soluble tumor necrosis factor receptors p55 and p75 in early onset neonatal sepsis. Early Hum Dev 52: 251-261.